The U.S. government is turning its back on a medical breakthrough that has saved millions of lives, halting $500 million in ...

Penn Medicine shows how sustained research investment drives innovation, economic growth, and global health breakthroughs.

Novartis agrees to acquire Avidity Biosciences, an innovator in RNA therapeutics, strengthening its late-stage neuroscience ...

ToolGen (KOSDAQ: 199800; CEO Jong-sang Ryu), a leader in genome editing technology, announced that the United States Patent ...

Researchers developed Bits2Bonds, a platform that merges molecular dynamics simulations with machine learning to design new ...

A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest ...

Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicines, today congratulates its scientific co-founder, Professor Chad A. Mirkin, on being awarded the ...

A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...

A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell ...

From custom gene editing to a discovery that could help stop pancreatic cancer before it starts, these advances offer a ...

LG Energy Solution said on the 8th that it signed a contract to supply electric-vehicle batteries to Mercedes-Benz (hereafter ...